A citation-based method for searching scientific literature

Chanhee Han, Stefania Bellone, Eric R Siegel, Gary Altwerger, Gulden Menderes, Elena Bonazzoli, Tomomi Egawa-Takata, Francesca Pettinella, Anna Bianchi, Francesco Riccio, Luca Zammataro, Ghanshyam Yadav, Jarrod A Marto, Marie-France Penet, Douglas A Levine, Ronny Drapkin, Abhijit Patel, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Gloria S Huang, Masoud Azodi, Peter E Schwartz, Alessandro D Santin. Gynecol Oncol 2018
Times Cited: 28







List of co-cited articles
116 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Development of a multimarker assay for early detection of ovarian cancer.
Zoya Yurkovetsky, Steven Skates, Aleksey Lomakin, Brian Nolen, Trenton Pulsipher, Francesmary Modugno, Jeffrey Marks, Andrew Godwin, Elieser Gorelik, Ian Jacobs,[...]. J Clin Oncol 2010
177
21

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Ian J Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Jatinderpal K Kalsi, Nazar N Amso, Sophia Apostolidou, Elizabeth Benjamin, Derek Cruickshank,[...]. Lancet 2016
491
21

Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses.
Robert L Coleman, Thomas J Herzog, Daniel W Chan, Donald G Munroe, Todd C Pappas, Alan Smith, Zhen Zhang, Judith Wolf. Am J Obstet Gynecol 2016
49
21

A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort.
Kathryn L Terry, Helena Schock, Renée T Fortner, Anika Hüsing, Raina N Fichorova, Hidemi S Yamamoto, Allison F Vitonis, Theron Johnson, Kim Overvad, Anne Tjønneland,[...]. Clin Cancer Res 2016
46
17


Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.
Laura J Havrilesky, Clark M Whitehead, Jennifer M Rubatt, Robert L Cheek, John Groelke, Qin He, Douglas P Malinowski, Timothy J Fischer, Andrew Berchuck. Gynecol Oncol 2008
154
14

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.
Richard G Moore, D Scott McMeekin, Amy K Brown, Paul DiSilvestro, M Craig Miller, W Jeffrey Allard, Walter Gajewski, Robert Kurman, Robert C Bast, Steven J Skates. Gynecol Oncol 2009
477
14

Serum protein markers for early detection of ovarian cancer.
Gil Mor, Irene Visintin, Yinglei Lai, Hongyu Zhao, Peter Schwartz, Thomas Rutherford, Luo Yue, Patricia Bray-Ward, David C Ward. Proc Natl Acad Sci U S A 2005
320
14

Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass.
Richard G Moore, M Craig Miller, Paul Disilvestro, Lisa M Landrum, Walter Gajewski, John J Ball, Steven J Skates. Obstet Gynecol 2011
154
14

Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability.
Erika Assarsson, Martin Lundberg, Göran Holmquist, Johan Björkesten, Stine Bucht Thorsen, Daniel Ekman, Anna Eriksson, Emma Rennel Dickens, Sandra Ohlsson, Gabriella Edfeldt,[...]. PLoS One 2014
574
10

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.
Daniel W Cramer, Robert C Bast, Christine D Berg, Eleftherios P Diamandis, Andrew K Godwin, Patricia Hartge, Anna E Lokshin, Karen H Lu, Martin W McIntosh, Gil Mor,[...]. Cancer Prev Res (Phila) 2011
196
10

Early detection biomarkers for ovarian cancer.
Sreeja Sarojini, Ayala Tamir, Heejin Lim, Shihong Li, Shifang Zhang, Andre Goy, Andrew Pecora, K Stephen Suh. J Oncol 2012
48
10

Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
10

The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer.
Martin Widschwendter, Michal Zikan, Benjamin Wahl, Harri Lempiäinen, Tobias Paprotka, Iona Evans, Allison Jones, Shohreh Ghazali, Daniel Reisel, Johannes Eichner,[...]. Genome Med 2017
65
10

Cancer Statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2017
10

Evaluation of HE4 and TTR for diagnosis of ovarian cancer: Comparison with CA-125.
Xin Zheng, Shulin Chen, Linfang Li, Xiaohua Liu, Xiaomin Liu, Shuqin Dai, Peng Zhang, Huaiwu Lu, Zhongqiu Lin, Yuefei Yu,[...]. J Gynecol Obstet Hum Reprod 2018
11
27




Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S Buys, Edward Partridge, Amanda Black, Christine C Johnson, Lois Lamerato, Claudine Isaacs, Douglas J Reding, Robert T Greenlee, Lance A Yokochi, Bruce Kessel,[...]. JAMA 2011
731
10

Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer.
Elieser Gorelik, Douglas P Landsittel, Adele M Marrangoni, Francesmary Modugno, Lyudmila Velikokhatnaya, Matthew T Winans, William L Bigbee, Ronald B Herberman, Anna E Lokshin. Cancer Epidemiol Biomarkers Prev 2005
194
10

Multiple biomarker algorithms to predict epithelial ovarian cancer in women with a pelvic mass: Can additional makers improve performance?
Richard G Moore, Alexandra Blackman, M Craig Miller, Katina Robison, Paul A DiSilvestro, Elizabeth E Eklund, Robert Strongin, Geralyn Messerlian. Gynecol Oncol 2019
12
25

Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer.
Madhumita Chatterjee, Laura C Hurley, Michael A Tainsky. Gynecol Oncol Rep 2017
12
25

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
Richard G Moore, Amy K Brown, M Craig Miller, Steven Skates, W Jeffrey Allard, Thorsten Verch, Margaret Steinhoff, Geralyn Messerlian, Paul DiSilvestro, C O Granai,[...]. Gynecol Oncol 2008
422
10


Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer.
Anna E Lokshin, Mathew Winans, Douglas Landsittel, Adele M Marrangoni, Lyudmila Velikokhatnaya, Francesmary Modugno, Brian M Nolen, Elieser Gorelik. Gynecol Oncol 2006
99
10

Microvesicle Proteomic Profiling of Uterine Liquid Biopsy for Ovarian Cancer Early Detection.
Georgina D Barnabas, Keren Bahar-Shany, Stav Sapoznik, Limor Helpman, Yfat Kadan, Mario Beiner, Omer Weitzner, Nissim Arbib, Jacob Korach, Tamar Perri,[...]. Mol Cell Proteomics 2019
18
16

Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis.
Lei Zhang, Ying Chen, Ke Wang. Curr Probl Cancer 2019
13
23


Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer.
Charlotte H Clarke, Christine Yip, Donna Badgwell, Eric T Fung, Kevin R Coombes, Zhen Zhang, Karen H Lu, Robert C Bast. Gynecol Oncol 2011
49
10


Multi-biomarker panel signature as the key to diagnosis of ovarian cancer.
Thingreila Muinao, Hari Prasanna Deka Boruah, Mintu Pal. Heliyon 2019
26
11

Reactivity of a monoclonal antibody with human ovarian carcinoma.
R C Bast, M Feeney, H Lazarus, L M Nadler, R B Colvin, R C Knapp. J Clin Invest 1981
10

Serum cytokine profiling as a diagnostic and prognostic tool in ovarian cancer: a potential role for interleukin 7.
Annechien J A Lambeck, Anne P G Crijns, Ninke Leffers, Wim J Sluiter, Klaske A ten Hoor, Mike Braid, Ate G J van der Zee, Toos Daemen, Hans W Nijman, W Martin Kast. Clin Cancer Res 2007
73
10

Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review.
Vincent Dochez, Hélène Caillon, Edouard Vaucel, Jérôme Dimet, Norbert Winer, Guillaume Ducarme. J Ovarian Res 2019
96
10


Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression.
Akira Kurosaki, Kosei Hasegawa, Tomomi Kato, Kenji Abe, Tatsuya Hanaoka, Akiko Miyara, Daniel J O'Shannessy, Elizabeth B Somers, Masanori Yasuda, Tetsuo Sekino,[...]. Int J Cancer 2016
45
7

Proteome-metabolome profiling of ovarian cancer ascites reveals novel components involved in intercellular communication.
Victoria O Shender, Marat S Pavlyukov, Rustam H Ziganshin, Georgij P Arapidi, Sergey I Kovalchuk, Nikolay A Anikanov, Ilya A Altukhov, Dmitry G Alexeev, Ivan O Butenko, Alexey L Shavarda,[...]. Mol Cell Proteomics 2014
62
7

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
7


A multiplex platform for the identification of ovarian cancer biomarkers.
Kristin L M Boylan, Kate Geschwind, Joseph S Koopmeiners, Melissa A Geller, Timothy K Starr, Amy P N Skubitz. Clin Proteomics 2017
14
14

Epidemiology of ovarian cancer: a review.
Brett M Reid, Jennifer B Permuth, Thomas A Sellers. Cancer Biol Med 2017
468
7

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
R C Bast, T L Klug, E St John, E Jenison, J M Niloff, H Lazarus, R S Berkowitz, T Leavitt, C T Griffiths, L Parker,[...]. N Engl J Med 1983
7

Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer.
Björg Kristjansdottir, Kristina Levan, Karolina Partheen, Karin Sundfeldt. Gynecol Oncol 2013
42
7

Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass.
Karolina Partheen, Björg Kristjansdottir, Karin Sundfeldt. J Gynecol Oncol 2011
54
7

Validation of a Novel Biomarker Panel for the Detection of Ovarian Cancer.
Felix Leung, Marcus Q Bernardini, Marshall D Brown, Yingye Zheng, Rafael Molina, Robert C Bast, Gerard Davis, Stefano Serra, Eleftherios P Diamandis, Vathany Kulasingam. Cancer Epidemiol Biomarkers Prev 2016
24
8

Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian Cancer.
Archana R Simmons, Charlotte H Clarke, Donna B Badgwell, Zhen Lu, Lori J Sokoll, Karen H Lu, Zhen Zhang, Robert C Bast, Steven J Skates. Int J Gynecol Cancer 2016
19
10

Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.
Zhi-Qiang Wang, Magdalena Bachvarova, Chantale Morin, Marie Plante, Jean Gregoire, Marie-Claude Renaud, Alexandra Sebastianelli, Dimcho Bachvarov. Oncotarget 2014
60
7

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients.
Xiaodan Meng, Simon A Joosse, Volkmar Müller, Fabian Trillsch, Karin Milde-Langosch, Sven Mahner, Maria Geffken, Klaus Pantel, Heidi Schwarzenbach. Br J Cancer 2015
84
7

A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment.
Hagen Kulbe, Probir Chakravarty, D Andrew Leinster, Kellie A Charles, Joseph Kwong, Richard G Thompson, Jermaine I Coward, Tiziana Schioppa, Stephen C Robinson, William M Gallagher,[...]. Cancer Res 2012
141
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.